LSL Pharma Group Inc. (TSXV: LSL)
Canada
· Delayed Price · Currency is CAD 0.350
0.00 (0.00%)
Dec 20, 2024, 1:19 PM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 38.70 million as of December 20, 2024. Its market cap has increased by 5.51% in one year.
Market Cap
38.70M
Enterprise Value
52.58M
Revenue
15.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 38.70M, a decrease of -37.24%. That is a compound annual growth rate of -22.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 38.70M | -3.19% |
| Dec 29, 2023 | 39.98M | -35.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.11B |
| Bausch Health Companies Inc. | 3.95B |
| WELL Health Technologies Corp. | 1.77B |
| dentalcorp Holdings Ltd. | 1.64B |
| Tilray Brands, Inc. | 1.64B |
| Curaleaf Holdings, Inc. | 1.59B |
| Sienna Senior Living Inc. | 1.31B |
| Cronos Group Inc. | 1.07B |